Home
Conditions
Hemic and Lymphatic Diseases

Clinical trial condition

Hemic and Lymphatic Diseases

Explore clinical trials studying Hemic and Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

21,127 public trials 3,991 recruiting studies

Refine in advanced search Browse all conditions

Hemic and Lymphatic Diseases trial results

Recruiting

SIM0718 Treatment of Asthma Clinical Study

NCT06488755

Conditions: Asthma; Eosinophilic, Eosinophilia, Hematologic Diseases, +6 more
Locations: China Japan Friendship Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Development of a Device for Evaluating Primary Hemostasis Under Whole Blood Flow Conditions

NCT03773159

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Blood Platelet Disorders, +10 more
Locations: CHU de Besançon Besançon, France

CHU Dijon Bourgogne Dijon, France

View Trial Details

Recruiting

Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers

NCT03207854

Conditions: Healthy Subject, Hematologic Diseases, Hematologic Neoplasms, +8 more
Locations: USC / Norris Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Recruiting

Sintilimab Combined With Chidamide in Treating Peripheral T Cell Lymphoma

NCT04512534

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Dongmei Ji Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)

NCT06351631

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +15 more
Locations: University of Michigan ( Site 6000) Ann Arbor, Michigan, United States

DUHS Duke Blood Cancer Center ( Site 6005) Durham, North Carolina, United States

The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C ( Site 6007) Columbus, Ohio, United States

UPMC Hillman Cancer Center ( Site 6004) Pittsburgh, Pennsylvania, United States

View all 21 locations

View Trial Details

Recruiting

CONNECT: A Multi-Cohort, Prospective Investigation of the Symani® Surgical System

NCT06866197

Conditions: Free Tissue Transfer, Hemic and Lymphatic Diseases, Lymphatic Diseases, +2 more
Locations: Saint Vincent's Hospital Melbourne Melbourne, Victoria, Australia

View Trial Details

Recruiting

Efficacy and Safety of CD19/CD20 CAR/TRuC-T in Relapsed/Refractory B-Cell Lymphoma

NCT07508605

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Shenzhen University General Hospital Shenzhen, Guangdong, China

View Trial Details

Recruiting

A Study of Treatment-free Remission in Chronic Phase Chronic Myeloid Leukemia

NCT06368414

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, Chronic Phase, +12 more
Locations: Gachon University Gil Medical Center Incheon, South Korea

View Trial Details

Recruiting

This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors

NCT06451497

Conditions: Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +58 more
Locations: Dana Farber Cancer Institute Boston, Massachusetts, United States

NEXT Oncology Austin, TX 78758, Texas, United States

NEXT Oncology San Antonio, Texas, United States

View Trial Details

Recruiting

Clinical Study of Venetoclax Combined With CACAG Regimen in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia

NCT06084819

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +5 more
Locations: Chinese PLA General Hospital Beijing, Beijing Municipality, China

View Trial Details

Hemic and Lymphatic Diseases

Hemic and Lymphatic Diseases trial results

Related conditions